Eap Osona Sud Alt Congost S.L.P.
- Address
- lock Available on a paid plan
Infectious Diseases and Vaccines
At Eap Osona Sud Alt Congost S.L.P. in Centelles, clinical research in virus diseases and bacterial infections and mycoses focuses on preventing and treating common infections such as COVID-19, cytomegalovirus infection, respiratory syncytial virus infections, herpes zoster, and acute vulvovaginal candidiasis. These studies are designed to assess vaccine protection, immune response, and the effectiveness and safety of new anti-infective therapies.
- Testing vaccines to help prevent COVID-19, CMV infection, RSV infection, and herpes zoster
- Evaluating treatment options for acute Candida vulvovaginitis and non-hospitalized COVID-19
- Measuring immune response and overall tolerability in adults and adolescents
The site’s family medicine setting supports research that is closely tied to everyday patient care, with a strong emphasis on prevention and practical infection management.
Cardiovascular and Lipid Disorders
Research in cardiovascular diseases and nutritional and metabolic diseases covers atherosclerotic cardiovascular disease, hypertension, hypercholesterolemia, hyperlipidemia, and elevated lipoprotein(a). The trials aim to reduce cardiovascular risk, improve cholesterol control, and evaluate whether new therapies can lower the chance of major heart and vascular events.
- Studying treatments for high cardiovascular risk and established cardiovascular disease
- Evaluating new approaches for hypertension and difficult-to-control blood pressure
- Testing therapies to improve LDL cholesterol and lipoprotein(a) levels
These studies reflect a broad effort to improve long-term cardiovascular prevention in adults at elevated risk.
Respiratory and Immune System Research
Within respiratory tract diseases and immune system diseases, the site is involved in studies of asthma and infection-related immune protection. The research includes evaluating inhaled treatment tolerability for asthma and examining how vaccines and boosters support immune responses in different age groups.
- Assessing the safety and tolerability of an inhaled therapy for asthma
- Measuring immune response after revaccination against RSV
- Studying booster vaccination responses in adolescents and adults
This area brings together chronic respiratory care and immunization research, both important for primary care populations.
Metabolic, Kidney, and Prevention-Focused Studies
Clinical trials at this hospital/clinic also address chronic kidney disease alongside metabolic and blood pressure-related conditions. The main goal is to explore whether new treatments can better protect kidney function, support blood pressure control, and reduce the burden of long-term cardiometabolic disease.
- Investigating therapies for chronic kidney disease in people with cardiometabolic risk
- Exploring treatment strategies for hypertension linked with obesity or overweight
- Supporting prevention-oriented research across cardiovascular and metabolic conditions
These trials highlight the site’s role in studies aimed at slowing disease progression and improving day-to-day health outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 8 therapeutic areas and 15 of 98 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 96 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Merck Sharp & Dohme LLC2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merck Sharp & Dohme LLC8trials
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Eap Osona Sud Alt Congost S.L.P.
lock Showing 1 of 27 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre randomized, double-blind, placebo-controlled, dose-finding, Phase 2 study (MARS-17) of GSK3858279 in adult participants with moderate to severe pain due to knee osteoarthritis. | Glaxosmithkline Research & Development Limited | Phase II | Not Recruiting | Nov 2023 | Aug 2024 |
IMP list
lock Showing 1 of 98 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| SARS-COV-2 VIRUS, VARIANTS B.1.351-B.1.1.7, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HETERODIMER | 3 | Unknown | 2023-05-26 | 2023-11-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.